Advent Pharma, an animal healthcare drugs manufacturer, makes its share trading debut today (Thursday) on the Dhaka and Chittagong Stock Exchanges under "N" category, officials said.
The DSE trading code for Advent Pharma is "ADVENT" and DSE company code is 18492 while the CSE scrip Id is 13032 and scrip code is "ADVENT".
The company, which raised a capital worth Tk 200 million from the public using fixed price method, floated 20 million ordinary shares of Tk 10 each.
The IPO subscription for shares of the company was open for resident and non-resident Bangladeshis on February 11 to February 19.
Bangladesh Securities & Exchange Commission (BSEC) approved the company's IPO proposal on January 2.
The company will use the IPO fund for acquisition of machinery and equipments of Tk 81.43 million, construction of building and other civil works Tk 100.07 million and IPO expenses of Tk 18.50 million.
As per un-audited financial reports for October to December quarter of 2017, the company's net profit after tax stood at Tk 15.30 million, pre-IPO earnings per share (EPS) stood at Tk 0.31 and post-IPO EPS was Tk 0.22.
In six months from July to December 2017, the company's net profit after tax was Tk 31.65 million, pre-IPO earnings per share (EPS) was Tk 0.65 and post-IPO EPS was Tk 0.46. The net asset value (NAV) per share was Tk. 13.11 as of December 31, 2017.
